Alps Advisors Inc Merus N.V. Transaction History

Alps Advisors Inc

$14.8 Billion
Q3 2024

A detailed history of Alps Advisors Inc transactions in Merus N.V. stock. As of the latest transaction made, Alps Advisors Inc holds 53,479 shares of MRUS stock, worth $2.66 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

53,479

Holding current value

$2.66 Million

% of portfolio

0.02%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$47.19 - $58.84 $2.52 Million - $3.15 Million	53,479 New	53,479 $2.67 Million
Q1 2024 May 14, 2024	BUY	$28.03 - $51.82 $19,621 - $36,274	700 Added 1.74%	40,828 $1.84 Million
Q4 2023 Feb 14, 2024	BUY	$20.06 - $28.66 $804,967 - $1.15 Million	40,128 New	40,128 $1.1 Million
Q1 2023 May 10, 2023	SELL	$14.25 - $20.5 $12,440 - $17,896	-873 Reduced 2.78%	30,513 $561,000
Q4 2022 Feb 14, 2023	BUY	$12.8 - $23.66 $81,459 - $150,572	6,364 Added 25.43%	31,386 $485,000
Q3 2022 Nov 14, 2022	SELL	$18.64 - $28.93 $15,061 - $23,375	-808 Reduced 3.13%	25,022 $501,000
Q2 2022 Aug 11, 2022	SELL	$13.98 - $29.25 $263,564 - $551,450	-18,853 Reduced 42.19%	25,830 $585,000
Q1 2022 May 16, 2022	SELL	$23.58 - $30.91 $126,553 - $165,893	-5,367 Reduced 10.72%	44,683 $1.18 Million
Q4 2021 Feb 09, 2022	BUY	$20.0 - $32.29 $1 Million - $1.62 Million	50,050 New	50,050 $1.59 Million
Q4 2020 Feb 03, 2021	SELL	$11.4 - $18.36 $422,335 - $680,182	-37,047 Closed	0 $0
Q3 2020 Nov 04, 2020	SELL	$10.57 - $16.0 $27,080 - $40,992	-2,562 Reduced 6.47%	37,047 $445,000
Q2 2020 Aug 05, 2020	SELL	$10.5 - $17.36 $121,600 - $201,046	-11,581 Reduced 22.62%	39,609 $637,000
Q1 2020 May 06, 2020	SELL	$11.34 - $19.44 $67,722 - $116,095	-5,972 Reduced 10.45%	51,190 $619,000
Q4 2019 Feb 07, 2020	BUY	$14.08 - $18.5 $804,840 - $1.06 Million	57,162 New	57,162 $805,000

Others Institutions Holding MRUS

# of Institutions

200

Shares Held

61.9M

Call Options Held

243K

Put Options Held

300K

Rtw Investments, LP New York, NY

4.17M
Shares

$207 Million
3.32% of portfolio
Deerfield Management Company, L.P. (Series C) New York, NY

3.41M
Shares

$169 Million
3.17% of portfolio
Commodore Capital LP New York, NY

3.35M
Shares

$166 Million
14.22% of portfolio
Wellington Management Group LLP Boston, MA

2.89M
Shares

$143 Million
0.03% of portfolio
Samlyn Capital, LLC New York, NY

2.61M
Shares

$130 Million
2.1% of portfolio

View Full List

About Merus N.V.

Ticker MRUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,878,200
Market Cap $2.28B
Description
Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...

More about MRUS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Account